The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.
about
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryTransplant-associated thrombotic microangiopathy: opening Pandora's box.Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 1.Automated measurement of schistocytes after bone marrow transplantation.Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).Thrombotic microangiopathies in bone marrow and organ transplant patients.Transplantation-associated thrombotic microangiopathy: twenty-two years later.Thrombotic thrombocytopenic purpura following stem cell transplantation.Therapeutic plasma exchange in patients with grade 2-3 hematopoietic stem cell transplantation-associated thrombotic thrombocytopenic purpura: a ten-year experience.Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution.Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease.Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.Case of anti-glomerular basement membrane antibody-induced glomerulonephritis with cytomegalovirus-induced thrombotic microangiopathy.Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxisOutcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1aHematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Post-bone marrow transplant thrombotic microangiopathy.Late effects of blood and marrow transplantation.Thrombotic microangiopathy in haematopoietic cell transplantation: an update.Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation.Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.Therapeutic apheresis for patients with cancer.Renal dysfunction following bone marrow transplantation.Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.Endothelial damage caused by cytomegalovirus and human herpesvirus-6.Post-transplant TMA: still waiting.
P2860
Q26992169-E583B18A-C1DE-4531-9269-80BF6539363FQ30235311-1903F873-2AB9-4F77-AD3D-AEF316255548Q30253063-041C4760-5D6F-42A1-8F31-0E32C95FDD8FQ33204276-4274C145-4E06-431E-A88C-BE102B9288C9Q33256286-4A16E36D-0B2E-4C28-890C-9DFB70B2020CQ33343954-937C6EF0-1305-41D1-B9FA-2E11BF3A6F5FQ33344694-A1F50F09-FF1F-4251-851B-8F6D88AB1FD6Q33345369-0196867D-4B4A-4A58-9A59-D0DB18024CB5Q33345682-C20E3D1F-8D0A-4A5A-A6CB-2BE0D386C0DAQ33349512-61E9AE3A-389C-4F93-8FFB-14AEBC853D55Q33359551-80BA9135-D3DA-4B88-B39D-E7830D22C21BQ33360049-D906B5AC-6A17-45A0-B501-A6942FD4B952Q33360252-BAC4D7EB-807C-442A-BB0C-26E3DB364DADQ33368614-9FA8074D-42B1-4648-A189-F92C7CEBB960Q33371965-056CEEE5-485B-4BFB-8A0F-4FE1A450F701Q33375739-67551EC5-B729-4BDD-89A3-7B531A5CC847Q33382787-D4A421EB-6420-490C-B255-3DF9FD9D47BDQ33384578-4E03D179-B217-4E90-8248-69847B0384EEQ33386308-A3E429F9-642E-4885-BAFF-A7677F2CEAA1Q33393068-6F20558D-9A48-4E72-945E-AA24982AC5F2Q33393944-98BB5E41-8CBD-4F99-97E4-62CCEB5F456BQ33398627-7AA1767C-22D4-4DFD-91D1-019FC388AC05Q33400326-E9256262-90DC-4E7B-A528-48A9BB4B5FD4Q33403897-28477EC5-F0CC-4B20-AFB9-BE1B1B8C9C0EQ33417690-4F6651B5-1B87-4276-AEAA-6083EF2AC002Q33418635-3AB57ACE-8709-4F9E-B029-B1D35E401F58Q33422969-9D1E6273-E6B7-4077-93C7-D006CC12D163Q33424902-411079BA-371A-4596-9CCE-3F34F525ADC2Q33428744-43E2AFD9-6D4E-4F70-8E48-F6A9D6103FDDQ33430697-7D03A089-E8D9-4E38-B736-E7E039DDC45EQ33574136-EC3F73C2-1FF9-4739-AB5E-E91CF67D026AQ35098992-223ADA4D-D214-4D4E-8673-74E9CBE0A755Q35920876-7A2A6B35-FEBB-41D9-AED5-FDA1D9982A46Q36266359-F260E09F-97EF-47E8-90B2-331C3E8637DBQ36585425-B59E7F1B-F381-4F2F-90B0-F97EA0B7B3B7Q38287610-2666E686-D07D-48D8-B9CB-B54FC762499DQ38944989-9BB52398-4918-4E8F-87B9-FD4FC4A108C1Q44272977-337FC881-4395-4E29-9CD8-C1F24A603F50Q44383243-62109972-B665-47E6-961A-C312554C3693Q46774802-9638DA8C-AA3E-4408-B71D-157535B577A8
P2860
The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The clinical features, risk fa ...... r bone marrow transplantation.
@ast
The clinical features, risk fa ...... r bone marrow transplantation.
@en
The clinical features, risk fa ...... r bone marrow transplantation.
@nl
type
label
The clinical features, risk fa ...... r bone marrow transplantation.
@ast
The clinical features, risk fa ...... r bone marrow transplantation.
@en
The clinical features, risk fa ...... r bone marrow transplantation.
@nl
prefLabel
The clinical features, risk fa ...... r bone marrow transplantation.
@ast
The clinical features, risk fa ...... r bone marrow transplantation.
@en
The clinical features, risk fa ...... r bone marrow transplantation.
@nl
P2093
P2860
P1476
The clinical features, risk fa ...... er bone marrow transplantation
@en
P2093
D H Pamphilon
J M Cornish
P2860
P356
10.1046/J.1365-2141.2001.02699.X
P407
P577
2001-04-01T00:00:00Z